Back to Search

Phase I trial of emavusertib (CA-4948) in combination with cisplatin, gemcitabine, and durvalumab in patients with untreated advanced or metastatic biliary tract cancer

  • Protocol Number: 202512063
  • Principal Investigator: Aranha, Olivia
  • Cancer Types: Gastrointestinal

Learn more about this study at: clinicaltrials.gov

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]